Research Article

Renoprotective potential of quercetin in experimental diabetic nephropathy: assesing antiapoptotic and antioxidant effects

Volume: 3 Number: 3 November 30, 2018
TR EN

Renoprotective potential of quercetin in experimental diabetic nephropathy: assesing antiapoptotic and antioxidant effects

Abstract

Aim: We investigated renoprotective and anti-apoptotic effects of quercetin, a potent bioflavonoid, by evaluating expression of apoptosis-regulatory genes that contribute to the kidney damage caused by diabetes in rats.

Methods: Rats were divided into 4 groups; Control, STZ-induced diabetic, STZ-induced diabetic+Quercetin and Quercetin control. Values of fasting blood glucose, body weight and urine microalbuminuria measured. Immunohistochemistry was performed using bax, bcl-2, caspase-3 antibodies. For apoptosis detection, TUNEL method was applied. Advanced oxidation protein products (AOPP), protein carbonyl oxidation (PCO), malondialdehyde (MDA) and superoxide dismutase (SOD) activity were measured in homogenized kidney tissues.

Results: Blood glucose and microalbuminuria levels were significantly decreased in quercetin-treated diabetic group compared to the untreated-diabetic group (p=0.020 and p=0.003; respectively).  MDA, AOPP and PCO levels were significantly decreased (p=0.001, p=0.0001 and p=0.0005; respectively); however, SOD activity were found to increase in quercetin-treated diabetic group (p=0.005). Immunostaining of bcl-2, bax and caspase-3 was decreased compared to the untreated-diabetic group. Apoptotic cells especially increased in the kidney tubuli of untreated-diabetic group and on the contrary, a significant decrease was observed in the group that received a quercetin treatment (p=0.0001).

Conclusion: Our results revealed that antiapoptotic effects of quercetin, which has predominantly antioxidant effects, may be useful in reducing effects of diabetic complications and preventing new complications.                                                                 

Keywords

References

  1. 1. Tucker BJ, Collins RC, Ziegler MG, Blantz, RC. Disassociation between glomeruler hyperfiltration and extracellular volume in diabetic rats. Kidney Int. 1991;39:1176-83.
  2. 2. King AJ. The use of animal models in diabetes research. Br J Pharmacol. 2012;166:877-94.
  3. 3. Tunçdemir M, Ozturk M. The effects of ACE inhibitor and angiotensin receptor blocker on clusterin and apoptosis in the kidney tissue of streptozotocin-diabetic rats. J Mol Histol. 2008;39:605-16.
  4. 4. Bolzan AD, Bianchi MS. Genotoxicity of streptozotocin. Mutat Res. 2002;512:121-34.
  5. 5. Gao Y, Chen ZY, Wang Y, Liu Y, Ma JX, Li YK. Long non‑coding RNA ASncmtRNA‑2 is upregulated in diabetic kidneys and high glucose‑treated mesangial cells. Exp Ther Med. 2017;13:581-87.
  6. 6. Ishikawa Y, Kitamura M. Bioflavonoid quercetin inhibits mitosis and apoptosis of glomerular cells in vitro and in vivo. Biochem Biophys Res Commun. 2000;279:629-34.
  7. 7. Jiang XS, Chen XM, Wan JM, Gui HB, Ruan XZ, Du XG. Autophagy Protects against Palmitic Acid-Induced Apoptosis in Podocytes in vitro. Sci Rep. 2017;7:42764.
  8. 8. Akef H, Kotb N, Abo-Elmatty D, Salem S. Anti-proliferative Effects of Androctonus amoreuxi Scorpion and Cerastes cerastes Snake Venoms on Human Prostate Cancer Cells. J Cancer Prev. 2017;22:40-6.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

November 30, 2018

Submission Date

August 9, 2018

Acceptance Date

September 14, 2018

Published in Issue

Year 2018 Volume: 3 Number: 3

APA
Tunçdemir, M., Büyükçolpan Mirzataş, E., & Uzun, H. (2018). Renoprotective potential of quercetin in experimental diabetic nephropathy: assesing antiapoptotic and antioxidant effects. Archives of Clinical and Experimental Medicine, 3(3), 179-185. https://doi.org/10.25000/acem.452530
AMA
1.Tunçdemir M, Büyükçolpan Mirzataş E, Uzun H. Renoprotective potential of quercetin in experimental diabetic nephropathy: assesing antiapoptotic and antioxidant effects. Arch Clin Exp Med. 2018;3(3):179-185. doi:10.25000/acem.452530
Chicago
Tunçdemir, Matem, Eda Büyükçolpan Mirzataş, and Hafize Uzun. 2018. “Renoprotective Potential of Quercetin in Experimental Diabetic Nephropathy: Assesing Antiapoptotic and Antioxidant Effects”. Archives of Clinical and Experimental Medicine 3 (3): 179-85. https://doi.org/10.25000/acem.452530.
EndNote
Tunçdemir M, Büyükçolpan Mirzataş E, Uzun H (November 1, 2018) Renoprotective potential of quercetin in experimental diabetic nephropathy: assesing antiapoptotic and antioxidant effects. Archives of Clinical and Experimental Medicine 3 3 179–185.
IEEE
[1]M. Tunçdemir, E. Büyükçolpan Mirzataş, and H. Uzun, “Renoprotective potential of quercetin in experimental diabetic nephropathy: assesing antiapoptotic and antioxidant effects”, Arch Clin Exp Med, vol. 3, no. 3, pp. 179–185, Nov. 2018, doi: 10.25000/acem.452530.
ISNAD
Tunçdemir, Matem - Büyükçolpan Mirzataş, Eda - Uzun, Hafize. “Renoprotective Potential of Quercetin in Experimental Diabetic Nephropathy: Assesing Antiapoptotic and Antioxidant Effects”. Archives of Clinical and Experimental Medicine 3/3 (November 1, 2018): 179-185. https://doi.org/10.25000/acem.452530.
JAMA
1.Tunçdemir M, Büyükçolpan Mirzataş E, Uzun H. Renoprotective potential of quercetin in experimental diabetic nephropathy: assesing antiapoptotic and antioxidant effects. Arch Clin Exp Med. 2018;3:179–185.
MLA
Tunçdemir, Matem, et al. “Renoprotective Potential of Quercetin in Experimental Diabetic Nephropathy: Assesing Antiapoptotic and Antioxidant Effects”. Archives of Clinical and Experimental Medicine, vol. 3, no. 3, Nov. 2018, pp. 179-85, doi:10.25000/acem.452530.
Vancouver
1.Matem Tunçdemir, Eda Büyükçolpan Mirzataş, Hafize Uzun. Renoprotective potential of quercetin in experimental diabetic nephropathy: assesing antiapoptotic and antioxidant effects. Arch Clin Exp Med. 2018 Nov. 1;3(3):179-85. doi:10.25000/acem.452530

Cited By